Announced
Completed
Financials
Sources
Tags
Panama
clinical research
vaccination clinical trials
Biotechnology
Acquisition
Completed
Friendly
Cross Border
Majority
Private
Single Bidder
Synopsis
Emmes, a full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, completed the acquisition of VaxTRIALS, a specialized Clinical Research Organization. Financial terms were not disclosed. “Both our companies have built enduring customer relationships and a legacy of service in vaccine and infectious disease research. I am proud that we have made both people and cultural development a priority, including hiring and developing employees who care deeply about making a difference in public health," Dr. José Jimeno, VaxTRIALS CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.